Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TROD Medical has developed Encage, a confined, bipolar radio frequency-based helical probe for minimally invasive focal ablation of soft tissues. The device is CE Mark approved for use in the European Economic Area and is undergoing clinical studies at leading centers including University College London Hospitals, Moffitt Cancer Centre, NYU School of Medicine, and Long Island Jewish School of Medicine. Early results suggest reduced risk of side effects compared to standard treatments for prostate cancer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TROD Medical.